Cancer-Associated Fibroblasts and Tumor-Associated Macrophages in Cancer and Cancer Immunotherapy.

Frontiers in Oncology
Hans RaskovIsmail Gögenur

Abstract

Our understanding of the tumor microenvironment (TME), including the interplay between tumor cells, stromal cells, immune cells, and extracellular matrix components, is mandatory for the innovation of new therapeutic approaches in cancer. The cell-cell communication within the TME plays a pivotal role in the evolution and progression of cancer. Cancer-associated fibroblasts (CAF) and tumor-associated macrophages (TAM) are major cell populations in the stroma of all solid tumors and often exert protumorigenic functions; however, the origin and precise functions of CAF and TAM are still incompletely understood. CAF and TAM hold significant potential as therapeutic targets to improve outcomes in oncology when combined with existing therapies. The regulation of CAF/TAM communication and/or their differentiation could be of high impact for improving the future targeted treatment strategies. Nevertheless, there is much scope for research and innovation in this field with regards to the development of novel drugs. In this review, we elaborate on the current knowledge on CAF and TAM in cancer and cancer immunotherapy. Additionally, by focusing on their heterogenous functions in different stages and types of cancer, we explore their rol...Continue Reading

References

Nov 19, 2004·Nature·Neil A BhowmickHarold L Moses
Jun 24, 2006·The Journal of Clinical Investigation·Markus LoefflerRalph A Reisfeld
Jul 5, 2006·The Journal of Immunology : Official Journal of the American Association of Immunologists·Andrew G JarnickiKingston H G Mills
May 29, 2008·International Journal of Cancer. Journal International Du Cancer·Ivan ShaboJoar Svanvik
Feb 6, 2010·Science·Frederic GeissmannKlaus Ley
Apr 8, 2010·Cell·Bin-Zhi Qian, Jeffrey W Pollard
Nov 26, 2010·Proceedings of the National Academy of Sciences of the United States of America·Dan G DudaRakesh K Jain
Jan 12, 2011·Proceedings of the National Academy of Sciences of the United States of America·Dimitrios IliopoulosKevin Struhl
Mar 8, 2011·Cell·Douglas Hanahan, Robert A Weinberg
Feb 3, 2012·Journal of Oral Pathology & Medicine : Official Publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology·Nobuyuki FujiiHisao Ito
Mar 2, 2012·The Journal of Clinical Investigation·Antonio Sica, Alberto Mantovani
Aug 29, 2012·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Shahab AsgharzadehRobert C Seeger
Sep 10, 2013·Angiogenesis·Nadine JettenMarjo M P C Donners
Nov 10, 2013·Nature Medicine·Dereck AmakyeMarion Dorsch
Nov 28, 2013·Proceedings of the National Academy of Sciences of the United States of America·Christine FeigDouglas T Fearon
Feb 20, 2014·Proceedings of the National Academy of Sciences of the United States of America·Daniel L AdamsMassimo Cristofanilli
Mar 19, 2014·Cancer Research·Eun-Jin YeoRichard A Lang
Jul 19, 2014·Immunity·Slava EpelmanGwendalyn J Randolph
Jul 30, 2014·The Journal of Experimental Medicine·Daniel ÖhlundDavid Tuveson
Aug 2, 2014·Cell·Ruth Scherz-ShouvalSusan Lindquist
Sep 19, 2014·Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association·Heng ZhangYihong Sun
Nov 22, 2014·Nature Reviews. Molecular Cell Biology·Caroline BonnansZena Werb
Feb 24, 2015·Nature Genetics·Alexandre CalonEduard Batlle
Mar 10, 2015·Current Treatment Options in Oncology·Bernd C Schmid, Martin K Oehler
Mar 17, 2015·Trends in Immunology·Renato OstuniGioacchino Natoli

❮ Previous
Next ❯

Citations

Jul 25, 2021·International Journal of Molecular Sciences·Carlos Jhovani Pérez-AmadoSilvia Jiménez-Morales

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Vaccines

Cancer vaccines are vaccines that either treat existing cancer or prevent development of a cancer.